Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Melina Wiedmann

Datos Biográficos

ID7965976
NOMBREMelina Wiedmann
NOMBRESMelina
APELLIDOWiedmann
FIRMAWIEDMANN M
AFILIACIONESTechnische Universität Dresden
ORCID0000-0001-7250-4329
VERIFICADOSí
TOTAL DE OBRAS2
TOTAL DE CITAS0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2022
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0
  • Evaluation of the multimodal Delta therapy for adolescents with substance use disorders

    Open Access•Lukas A Basedow, Sören Kuitunen-Paul et al.•ARTICLE•Frontiers in Psychiatry•2024

    DELTA showed small effects on SUD-related and depression-related variables. However, the interpretation is limited by the small sample size. Nonetheless, the DELTA intervention is viable in SUD outpatient treatment and will be further evaluated. Clinical trial registration : The study was registered at clinicaltrials.gov under NCT03444974. Registered February, 26th 2018 (https://clinicaltrials.gov/ct2/show/NCT03444974)

  • Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use

    Open Access•Melina Wiedmann, Sören Kuitunen-Paul et al.•ARTICLE•Frontiers in Psychiatry•2022

    Our results indicate that MDMA use additional to cannabis use is associated with APS among adolescent SUD patients. Contrary to our expectations, we did not see an association of cannabis use and APS. We speculate that cannabis increases the risk for psychosis after a longer period of use and in combination with other risk factors, such as trauma history. Clinicians should screen for APS among SUD patients using MDMA and cannabis in order to adap…

Sin obras prominentes en esta página.

  • Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use

    Open Access•Melina Wiedmann, Sören Kuitunen-Paul et al.•ARTICLE•Frontiers in Psychiatry•2022

    Our results indicate that MDMA use additional to cannabis use is associated with APS among adolescent SUD patients. Contrary to our expectations, we did not see an association of cannabis use and APS. We speculate that cannabis increases the risk for psychosis after a longer period of use and in combination with other risk factors, such as trauma history. Clinicians should screen for APS among SUD patients using MDMA and cannabis in order to adap…

  • Evaluation of the multimodal Delta therapy for adolescents with substance use disorders

    Open Access•Lukas A Basedow, Sören Kuitunen-Paul et al.•ARTICLE•Frontiers in Psychiatry•2024

    DELTA showed small effects on SUD-related and depression-related variables. However, the interpretation is limited by the small sample size. Nonetheless, the DELTA intervention is viable in SUD outpatient treatment and will be further evaluated. Clinical trial registration : The study was registered at clinicaltrials.gov under NCT03444974. Registered February, 26th 2018 (https://clinicaltrials.gov/ct2/show/NCT03444974)

Medicine (2 obras) · Psychiatry (2 obras) · Psychology (2 obras) · Abstinence (1 obras) · Attention Deficit Hyperactivity Disorder (1 obras) · Behavioral and Psychological Studies (1 obras) · Cannabis (1 obras) · Cannabis and Cannabinoid Research (1 obras) · Child and Adolescent Psychosocial and Emotional Development (1 obras) · Clinical Psychology (1 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae